Logo-apb
Adv Pharm Bull. 2023;13(1): 88-95. doi: 10.34172/apb.2023.007
PMID: 36721805        PMCID: PMC9871265

Mini Review

Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment

LuĂ­sa Biscaglia Miquelotti 1 ORCID, Marcel Henrique Marcondes Sari 2 ORCID, Luana Mota Ferreira 1,3 * ORCID

Cited by CrossRef: 1


1- Staropoli N, Salvino A, Falcone F, Farenza V, Costa M, Rossini G, Manti F, Crispino A, Riillo C, Ciliberto D, Arbitrio M, Tassone P, Tagliaferri P. Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity. Front Oncol. 2023;13 [Crossref]
2- Balachandran D, Bashoura L, Sheshadri A, Manzullo E, Faiz S. The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer. Front Oncol. 2023;13 [Crossref]
3- Ma M, Li L, Yang S, Huang C, Zhuang W, Huang S, Xia X, Tang Y, Li Z, Zhao Z, Chen Q, Qiao G, Lian Z. Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma . OncoImmunology. 2024;13(1) [Crossref]